Viemed Healthcare, Inc. · NASDAQ:VMD
Viemed Healthcare — Q2 2025 Earnings Presentation
10 slides from Viemed Healthcare's earnings presentation, Aug 6, 2025
Slide 1: Financial Supplement Second Quarter 2025
Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care August 6, 2025 1 Second Quarter 2025
Slide 2: Disclaimers
Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or “forward-looking information” as such term is defined in applicable Canadian
Slide 3: Key Themes for Q2 2025
Key Themes for Q2 2025 3 Solid execution with record second-quarter results and continued momentum in our core vent and sleep therapy businesses. SG&A improvements fueled by favorable product mix drove strong margin stability and enhanced profitability. Repurchased $1.8 million worth of common share
Slide 4: Financial and Operational Highlights
Financial and Operational Highlights 4 (expressed in thousands of U.S. Dollars, except operational information). (1) Refer to "Non-GAAP Reconciliations" in this presentation for definition of Adjusted EBITDA and a reconciliation to its most comparable GAAP measure. (2) Vent Patients represents the n
Slide 5: Service, Payor and Revenue Mix
Medicare 40% Medicaid/ MCO 8% Medicare Advantage 22% Commercial 18% Other 12% Ventilation 54% Sleep 19% Oxygen 10% Other 17% Q2 2025 Rental 76% Sales 24% Medicare 42% Medicaid/ MCO 8% Medicare Advantage 20% Commercial 19% Other 11% Ventilation 56% Sleep 16% Oxygen 10% Other 18% Q2 2024 Service, Payo
Slide 6: Revenue Highlights
Revenue Highlights 6 For the quarter ended 6/30/25 3/31/25 12/31/24 9/30/24 6/30/24 3/31/24 12/31/23 9/30/23 Rental Revenue (expressed in thousands of USD): Ventilators, non-invasive & invasive $33,819 $32,159 $33,173 $31,772 $30,445 $29,187 $29,077 $28,322 Other home medical equipment rentals $13,8
Slide 7: Net CAPEX
Net CAPEX 7 For the quarter ended 6/30/25 3/31/25 12/31/24 9/30/24 6/30/24 3/31/24 12/31/23 9/30/23 Purchase of property and equipment 8,129 15,483 11,829 11,002 8,934 6,006 7,932 7,402 Proceeds from sale of property and equipment (6,402) (6,953) (2,881) (6,033) (766) (641) (460) (353) Net CAPEX 1,7
Slide 8: Liquidity Metrics
Liquidity Metrics 8 Positioned for growth • The Company maintains a healthy balance sheet with no net debt as of June 30, 2025, providing significant financial flexibility. • As of June 30, 2025, the Company had $55 million in unfunded commitments available under its existing credit facilities, supp
Slide 9: 2025 Guidance – Commentary
2025 Guidance – Commentary 9 Core Metrics • Net revenue of $271 million to $277 million; an increase from $256 million to $265 million • Adjusted EBITDA of $59 million to $62 million (22% of net revenue); an increase from $55 million to $58 million • Both increases are primarily related to inclusion
Slide 10: Non-GAAP Reconciliations
Non-GAAP Reconciliations 10 (a) Represents non-cash, equity-based compensation expense associated with option and RSU awards. (b) Represents transaction costs and expenses related to acquisition and integration efforts associated with recently announced or completed acquisitions. (c) Represents impa